Mostrar registro simples

dc.contributor.authorVettorato, Rodrigopt_BR
dc.contributor.authorHeidrich, Daianept_BR
dc.contributor.authorGomes, Fernanda Fragapt_BR
dc.contributor.authorRibeiro, Amanda Carvalhopt_BR
dc.contributor.authorPagani, Danielle Machadopt_BR
dc.contributor.authorTimotheo, Carina Alvespt_BR
dc.contributor.authorAmaro, Tais Guarientipt_BR
dc.contributor.authorVettorato, Gersonpt_BR
dc.contributor.authorScroferneker, Maria Luciapt_BR
dc.date.accessioned2018-02-20T02:25:42Zpt_BR
dc.date.issued2018pt_BR
dc.identifier.issn2211-7539pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/172646pt_BR
dc.description.abstractWe report a case of a patient with lymphocutaneous sporotrichosis in the right upper limb. The fungus was identified as Sporothrix schenckii senso stricto by calmodulin gene sequencing. The initial treatment was itraconazole (200 mg/day), but in vitro antifungal susceptibility demonstrated high resistant to this and another six antifungals, with exception to terbinafine. The lesions did not regress with itraconazole treatment. Thus, 500 mg/day of terbinafine was prescribed and clinical cure was obtained after four months.en
dc.format.mimetypeapplication/pdf
dc.language.isoengpt_BR
dc.relation.ispartofMedical mycology case reports. [Amsterdam]. Vol. 19 (Mar. 2018), p. 18-20pt_BR
dc.rightsOpen Accessen
dc.subjectSporotrichosisen
dc.subjectSporothrix schenckiipt_BR
dc.subjectSporothrix schenckiien
dc.subjectAntifúngicospt_BR
dc.subjectEsporotricosept_BR
dc.subjectSenso strictoen
dc.subjectItraconazolpt_BR
dc.subjectItraconazoleen
dc.subjectTerbinafineen
dc.subjectAntifungal susceptibilityen
dc.titleSporotrichosis by Sporothrix schenckii senso stricto with itraconazole resistance and terbinafine sensitivity observed in vitro and in vivo : case reportpt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001059495pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples